Huahai Pharmaceutical offers sixth optional put-back for convertible bonds

Zhejiang Huahai Pharmaceutical Co., Ltd. has initiated the sixth optional put-back for its "Huahai Convertible Bonds" as its stock price fell below 70% of the current conversion price for 30 consecutive trading days. The put-back price is RMB 100.30 per bond, including current interest and taxes. This price reflects a 2.00% annual interest rate over 54 days (November 2, 2025, to December 26, 2025), yielding an interest component of approximately RMB 0.30 per bond.

The put-back period is scheduled from December 22, 2025, to December 26, 2025. During this time, bondholders can submit requests through the Shanghai Stock Exchange trading system. The company will disburse funds for the put-back on December 31, 2025.

During the put-back period, "Huahai Convertible Bonds" will continue to trade but will no longer be convertible into shares. Bondholders have the option to sell all or part of their untransferred convertible bonds; this put-back is not mandatory. The company also warns that the current market price for "Huahai Convertible Bonds" is higher than the put-back price, so opting for the put-back might result in a loss for investors.